These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6274814

  • 1. Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA.
    Lanier AP, Bornkamm GW, Henle W, Henle G, Bender TR, Talbot ML, Dohan PH.
    Int J Cancer; 1981 Sep 15; 28(3):301-5. PubMed ID: 6274814
    [Abstract] [Full Text] [Related]

  • 2. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Fåhraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P.
    Int J Cancer; 1988 Sep 15; 42(3):329-38. PubMed ID: 2843473
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes.
    Saemundsen AK, Albeck H, Hansen JP, Nielsen NH, Anvret M, Henle W, Henle G, Thomsen KA, Kristensen HK, Klein G.
    Br J Cancer; 1982 Nov 15; 46(5):721-8. PubMed ID: 6293523
    [Abstract] [Full Text] [Related]

  • 4. In situ detection of Epstein-Barr virus markers in nasopharyngeal carcinoma patients.
    Lung ML, Chan KH, Lam WP, Kou SK, Choy D, Chan CW, Ng MH.
    Oncology; 1989 Nov 15; 46(5):310-7. PubMed ID: 2550863
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB.
    J Gen Virol; 1988 May 15; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [Abstract] [Full Text] [Related]

  • 6. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
    Hewetson JF, Levine PH, Neubauer RH, Rabin H.
    Int J Cancer; 1982 Nov 15; 30(5):581-5. PubMed ID: 6295966
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland.
    Lanier AP, Clift SR, Bornkamm G, Henle W, Goepfert H, Raab-Traub N.
    Arctic Med Res; 1991 Apr 15; 50(2):55-61. PubMed ID: 1646614
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].
    Chen XY, Ning S, Arrand JR.
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug 15; 23(4):200-3. PubMed ID: 7805145
    [Abstract] [Full Text] [Related]

  • 10. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T.
    Cancer; 1984 Feb 01; 53(3):430-40. PubMed ID: 6318948
    [Abstract] [Full Text] [Related]

  • 11. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
    Sun N, Chen X.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995 Feb 01; 30(4):213-5. PubMed ID: 8745459
    [Abstract] [Full Text] [Related]

  • 12. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
    Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I.
    J Virol; 1991 Mar 01; 65(3):1558-67. PubMed ID: 1847471
    [Abstract] [Full Text] [Related]

  • 13. Attachment of antinuclear antibodies to nasopharyngeal carcinoma or other cells during preparation of biopsy imprints.
    Henle W, Henle G, Lanier AP, Bornkamm GW.
    J Natl Cancer Inst; 1986 Jun 01; 76(6):1041-6. PubMed ID: 3012176
    [Abstract] [Full Text] [Related]

  • 14. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
    Chen DY, Chen YM, Lan JL, Chen HH, Hsieh CW, Wey SJ, Lu JJ.
    J Clin Virol; 2010 Dec 01; 49(4):290-5. PubMed ID: 20934910
    [Abstract] [Full Text] [Related]

  • 15. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
    Chen MR, Tsai CH, Wu FF, Kan SH, Yang CS, Chen JY.
    J Gen Virol; 1999 Feb 01; 80 ( Pt 2)():447-455. PubMed ID: 10073707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.
    Sternås L, Middleton T, Sugden B.
    J Virol; 1990 May 01; 64(5):2407-10. PubMed ID: 2157896
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck.
    Ringborg U, Henle W, Henle G, Ingimarsson S, Klein G, Silfversward C, Strander H.
    Cancer; 1983 Oct 01; 52(7):1237-43. PubMed ID: 6309355
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z, Koprowski H, Andersson-Anvret M, Klein G.
    J Cell Physiol; 1978 Oct 01; 97(1):1-8. PubMed ID: 213442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.